1-alpha-24-dihydroxyvitamin-d3 has been researched along with Breast-Neoplasms* in 2 studies
2 other study(ies) available for 1-alpha-24-dihydroxyvitamin-d3 and Breast-Neoplasms
| Article | Year |
|---|---|
Vitamin D Compounds PRI-2191 and PRI-2205 Enhance Anastrozole Activity in Human Breast Cancer Models.
Topics: Anastrozole; Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Calcitriol; Dihydroxycholecalciferols; Female; Humans; MCF-7 Cells; Mice; Mice, SCID; Xenograft Model Antitumor Assays | 2021 |
Steroid hormone calcitriol and its analog tacalcitol inhibit miR-125b expression in a human breast cancer MCF-7 cell line.
MiR-125b belongs to the class of microRNAs, which are short endogenous non-coding RNAs that negatively regulate gene expression at the post-transcriptional level. Recently, it was reported that miR-125b was found to promote migration and invasion of MCF-7 cells and was involved in chemotherapeutic resistance. Decreasing miR-125b expression would have potential therapeutic significance in preventing dissemination of breast cancer cells. The objective of this study was to evaluate miR-125b expression levels in MCF-7 cells following treatment with 1,25-dihydroxyvitamin D Topics: Antineoplastic Agents; Breast Neoplasms; Calcitriol; Cell Proliferation; Dihydroxycholecalciferols; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; MCF-7 Cells; MicroRNAs; Molecular Conformation; Reverse Transcriptase Polymerase Chain Reaction; Structure-Activity Relationship | 2019 |